Ritonavir Completed Phase 2 Trials for Chronic Delta Hepatitis Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02527707Titrating-Dose of Lonafarnib in Combination With Ritonavir